Cited by 148Hormonal and reproductive studiesAdipokines, Inflammation, and Metabolic DiseasesRegulation of Appetite and Obesity

Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review

Open access
Saad, Farid, Aversa, Antonio, M. Isidori, Andrea, J. Gooren, Louis·2012·Current Diabetes Reviews

Abstract

OBJECTIVE: Obesity negatively affects human health. Limiting food intake, while producing some weight loss, results in reduction of lean body mass. Combined with moderate exercise it produces significant weight loss, maintains lean body mass and improves insulin sensitivity, but appears difficult to adhere to. Bariatric surgery is clinically effective for severely obese individuals compared with non-surgical interventions, but has limitations. Clinical and pre-clinical studies have implicated a role for testosterone (T) in the patho-physiology of obesity. EVIDENCE ACQUISITION AND SYNTHESIS: A literature search in PubMed on the role of T in counteracting obesity and its complications. RESULTS: Obesity per se impairs testicular T biosynthesis. Furthermore, lower-than-normal T levels increase accumulation of fat depots, particularly abdominal (visceral) fat. This fat distribution is associated with development of metabolic syndrome (MetS) and its sequels, namely type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). T treatment reverses fat accumulation with significant improvement in lean body mass, insulin sensitivity and biochemical profiles of cardiovascular risk. The contribution of T to combating obesity in hypogonadal men remains largely unknown to medical professionals managing patients with obesity and metabolic syndrome. Many physicians associate T treatment in men with risks for prostate malignancy and CVD. These beliefs are not supported by recent insights. CONCLUSION: While overall treatment of obesity is unsuccessful, T treatment of hypogonadal men may be effective, also because it improves mood, energy, reduces fatigue and may motivate men to adhere to diet and exercise regimens designed to combat obesity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/157339912799424573

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Saad, F., Aversa, A., M. Isidori, A., & J. Gooren, L.
Affiliations
Bayer (Germany) (DE)
Corresponding author
Saad, Farid
Venue
Current Diabetes Reviews
Published
2012-03-01
Volume
8
Issue
2
Pages
131-143
ISSN
1573-3998 (ISSN-L)
OpenAlex
W2138332837
Cited by
148
References
109
Citations by year
2026: 6 · 2025: 1 · 2024: 3 · 2023: 8 · 2022: 9 · 2021: 7 · 2020: 3 · 2019: 4 · 2018: 14 · 2017: 11 · 2016: 6 · 2015: 28 · 2014: 16 · 2013: 26 · 2012: 6
FWCI
19.51
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Current Diabetes Reviews (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
testosterone replacement therapy, obesity, hypogonadism, metabolic syndrome, visceral fat, lean body mass, insulin sensitivity, type 2 diabetes, cardiovascular risk, prostate cancer risk, bariatric surgery, weight loss, medication adherence
MeSH terms
Diabetes Mellitus, Type 2, Diet, Reducing, Humans, Hypogonadism, Male, Obesity, Patient Compliance, Testosterone, Exercise, Metabolic Syndrome, Risk Reduction Behavior, Intra-Abdominal Fat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review